MetrionAIIntelligence

Sign in Register

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading market dashboard

My Watchlist

Sign in to track securities

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading news article

Back to markets

zacks.com/April 23, 2026 at 10:20 AMSNY

Sanofi Tops Q1 Earnings Estimates as Dupixent & New Drugs Drive Growth

Sanofi beats Q1 estimates as Dupixent and new drugs fuel double-digit growth, with strong sales and earnings gains supporting its 2026 outlook.

Open original source